GGrantIndex
← Search

Leadership, Planning and Evaluation

$204,393P30FY2023CANIH

Roswell Park Cancer Institute Corp, Buffalo NY

Investigators

Linked publications, trials & patents

Trial NCT07082270Trial NCT06202066Trial NCT05589844Trial NCT05338905Trial NCT05292521Trial NCT05231122Trial NCT04607291Trial NCT04533542Trial NCT04530812Trial NCT04526587Trial NCT04379518Trial NCT04358315Trial NCT04348747Trial NCT04298606Trial NCT04290962Trial NCT04269213Trial NCT04231539Trial NCT04207190Trial NCT04119830Trial NCT04110249Trial NCT04109924Trial NCT04093323Trial NCT04081389Trial NCT04073745Trial NCT04068649Trial NCT04067830Trial NCT04060446Trial NCT04032418Trial NCT04000581Trial NCT03965234Trial NCT03935347Trial NCT03899987Trial NCT03897270Trial NCT03895918Trial NCT03881735Trial NCT03880422Trial NCT03879694Trial NCT03865472Trial NCT03851081Trial NCT03793907Trial NCT03789877Trial NCT03751449Trial NCT03751436Trial NCT03736720Trial NCT03735589Trial NCT03735095Trial NCT03727789Trial NCT03727061Trial NCT03709550Trial NCT03691376Trial NCT03688945Trial NCT03685695Trial NCT03683147Trial NCT03680235Trial NCT03679585Trial NCT03679559Trial NCT03678350Trial NCT03630601Trial NCT03574792Trial NCT03457142Trial NCT03403634Trial NCT03384836Trial NCT03358719Trial NCT03348748Trial NCT03333486Trial NCT03297489Trial NCT03211416Trial NCT03206047Trial NCT03192397Trial NCT03090412Trial NCT03017131Trial NCT03011736Trial NCT02965976Trial NCT02955290Trial NCT02953457Trial NCT02947386Trial NCT02877641Trial NCT02857374Trial NCT02853318Trial NCT02833506Trial NCT02713373Trial NCT02650986Trial NCT02575885Trial NCT02575508Trial NCT02531906Trial NCT02474095Trial NCT02455557Trial NCT02452463Trial NCT02414724Trial NCT02399215Trial NCT02393755Trial NCT02334865Trial NCT02287727Trial NCT02227940Trial NCT02170389Trial NCT02166905Trial NCT02159950Trial NCT02119728Trial NCT02100254Trial NCT02072486

Abstract

The Roswell Park Cancer Comprehensive Cancer Center planning and evaluation process is overseen by the Cancer Center Director, Dr. Candace Johnson, who is also the President and CEO. Planning and Evaluation efforts serve as the framework for effective internal and external advice, developing and implementing the strategic planning process, setting priorities, overseeing shared resources, research programs, and clinical operations. Strategic planning and ongoing evaluation is critical to the success of the Cancer Center in making progress towards its scientific, clinical, prevention and education mission. The Executive Council and the CCSG Steering Committee are the central decision-making and internal advisory bodies, with the goal to foster and encourage research productivity, promote interaction and collaboration, and take maximum advantage of institutional strengths and unique scientific opportunities. The continuous cycle of planning and evaluation allows leaders to make adjustments to priorities and resource allocation, develop future plans. During the current funding period, a comprehensive strategic planning and evaluation effort was undertaken for the Center. This led to a five-year CCSG and clinical strategic plan that robustly aligns programmatic initiatives, capital projects, and organizational priorities for the Cancer Center with a financial plan; and further integration of the clinical and research missions. External and internal advisory groups provided exceptional guidance and recommendations to the senior leaders. Besides the Executive Council and the CCSG Steering Committees, the CCSG External Advisory Board, program-specific advisory boards, Senior Leadership Group, Shared Resource Advisory Committees, individual program meetings and retreats, and Disease Site Research Group provide multiple forums to solicit and discuss feedback and critique to inform and improve the cancer center.

View original record on NIH RePORTER →